Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Simple Diagnostic Algorithm for the Prediction of JAK2 Mutation Status in Erythrocytosis Based on Complete Blood Count Data: A Multi-Center Retrospective Analysis

Keiko Maeyama, Yuka Sugimoto, Keiki Nagaharu, Eiko Oya, Eri Miyata, Atsushi Fujieda, Hiroyuki Miyashita, Takao Sekine, Shigehisa Tamaki, Kohshi Ohishi, Isao Tawara

Blood (2024) 144 (Supplement 1): 1789.

https://doi.org/10.1182/blood-2024-199350

Published: 2024

Journal Articles

Combining the Number of Infectious Episodes and Interval of Chemotherapy to Transplantation May Predict a Transplant Outcome in Patients with Acute Myeloid Leukemia: A Retrospective Analysis of JALSG AML201 Study

Satoshi Kaito, MD, Noriko Doki, MD PhD, Yuho Najima, MD, Shigeki Ohtake, MD PhD, Hitoshi Kiyoi, MD PhD, Hiroyuki Fujita, MD PhD, Yasushi Miyazaki, MD PhD, Noriko Usui, MD PhD, Hirokazu Okumura, MD PhD, Koichi Miyamura, MD PhD, Emiko Sakaida, MD PhD, Atsushi Fujieda, MD PhD, Nagai Tadashi, MD PhD, Takahisa Yamane, MD PhD, Ohnishi Kazunori, MD PhD, Tomoki Naoe, MD PhD, Kazuteru Ohashi, MD PhD

Blood (2018) 132 (Supplement 1): 4643.

https://doi.org/10.1182/blood-2018-99-114565

Published: 2018

Journal Articles

PCR Analysis of Bacteria and Fungi in Early Phase of Hematopoietic Stem Cell Transplantation

Atsushi Fujieda, MD, PhD, Akiko Nakamura, Kohshi Ohishi, MD, PhD, Fumihiko Monma, MD, PhD, Masahiro Masuya, MD, PhD, Kazunori Nakase, MD, PhD, Yoshiko Matsushima, Hideo Wada, MD, PhD, Tsutomu Nobori, MD, PhD, Naoyuki Katayama, MD, PhD

Blood (2011) 118 (21): 1963.

https://doi.org/10.1182/blood.V118.21.1963.1963

Published: 2011

Journal Articles

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

Blood (2011) 117 (8): 2358–2365.

https://doi.org/10.1182/blood-2010-03-273243

Published: 2011

Journal Articles

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

Blood (2011) 117 (8): 2366–2372.

https://doi.org/10.1182/blood-2010-07-295279

Published: 2011

Journal Articles

Phase 2 Study of FLAGM (Fludarabine+High-Dose Ara-C +G-CSF+Mitoxantrone) for Relapsed or Refractory Acute Myeloid Leukemia (AML): A Report From the Japan Adult Leukemia Study Group (JALSG).

Shuichi Miyawaki, MD, PhD, Naoko Hatsumi, MD, Takahiro Yamauchi, MD, Kousuke Tsuboi, MD, Atsushi Fujieda, MD, Akihiro Takeshita, MD, Norio Komatsu, MD, Noriko Usui, MD, Yukihiro Arai, MD, Fumihiro Ishida, MD, PhD, Takeshi Morii, MD, Yasuhiko Kano, MD, Michinori Ogura, MD, PhD, Noriko Doki, MD, Kazunori Ohnishi, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2009) 114 (22): 1058.

https://doi.org/10.1182/blood.V114.22.1058.1058

Published: 2009

Journal Articles

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.

Yoshihiro Hatta, Shuichi Mizuta, Shigeki Ohtake, MD, PhD, Isamu Sugiura, MD, PhD, Yasunori Ueda, MD, Heiwa Kanamori, Hideki Akiyama, Makoto Takeuchi, Noriko Usui, Toshiaki Yujiri, Atsushi Fujieda, Toru Kiguchi, MD, Itsuro Jinnai, MD, Tomoki Naoe, MD, PhD, Ryuzo Ohno, MD

Blood (2009) 114 (22): 3090.

https://doi.org/10.1182/blood.V114.22.3090.3090

Published: 2009

Journal Articles

Age-Related Risk of Non-Relapse Mortality Associated with Acute Graft-Versus-Host Disease.

Takahiro Fukuda, Yukiko Iisaka, Fusako Ohara, Atsushi Fujieda, Satoshi Yamasaki, Sung-Won Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 40.

https://doi.org/10.1182/blood.V108.11.40.40

Published: 2006

Journal Articles

Impact of Hepatic Toxicities on Survival after Allogeneic Hematopoietic Cell Transplantation (HCT): Comparison of Reduced-Intensity Versus Conventional Conditioning Regimens at a Single Center.

Atsushi Fujieda, Takahiro Fukuda, Fusako Ohara, Satoshi Yamasaki, Sungwon Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Atsushi Makimoto, Kensei Tobinai, Yoichi Takaue

Blood (2006) 108 (11): 2976.

https://doi.org/10.1182/blood.V108.11.2976.2976

Published: 2006

Journal Articles

Possible Involvement of Histone Acetylation in Differentiation of Erythroid Precursors and Proliferation of Granulocytic Precursors.

Atsushi Fujieda, MD, Naoyuki Katayama, MD, Kohshi Ohishi, MD, Masahiro Masuya, MD, Hiroshi Shiku, MD

Blood (2004) 104 (11): 4238.

https://doi.org/10.1182/blood.V104.11.4238.4238

Published: 2004

Journal Articles

Reprogramming of human postmitotic neutrophils into macrophages by growth factors

Hiroto Araki, Naoyuki Katayama, Yoshihiro Yamashita, Hiroyuki Mano, Atsushi Fujieda, Eiji Usui, Hidetsugu Mitani, Kohshi Ohishi, Kazuhiro Nishii, Masahiro Masuya, Nobuyuki Minami, Tsutomu Nobori, Hiroshi Shiku

Blood (2004) 103 (8): 2973–2980.

https://doi.org/10.1182/blood-2003-08-2742

Published: 2004

NARROW

A Simple Diagnostic Algorithm for the Prediction of JAK2 Mutation Status in Erythrocytosis Based on Complete Blood Count Data: A Multi-Center Retrospective Analysis

Combining the Number of Infectious Episodes and Interval of Chemotherapy to Transplantation May Predict a Transplant Outcome in Patients with Acute Myeloid Leukemia: A Retrospective Analysis of JALSG AML201 Study

PCR Analysis of Bacteria and Fungi in Early Phase of Hematopoietic Stem Cell Transplantation

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

Phase 2 Study of FLAGM (Fludarabine+High-Dose Ara-C +G-CSF+Mitoxantrone) for Relapsed or Refractory Acute Myeloid Leukemia (AML): A Report From the Japan Adult Leukemia Study Group (JALSG).

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.

Age-Related Risk of Non-Relapse Mortality Associated with Acute Graft-Versus-Host Disease.

Impact of Hepatic Toxicities on Survival after Allogeneic Hematopoietic Cell Transplantation (HCT): Comparison of Reduced-Intensity Versus Conventional Conditioning Regimens at a Single Center.

Possible Involvement of Histone Acetylation in Differentiation of Erythroid Precursors and Proliferation of Granulocytic Precursors.

Reprogramming of human postmitotic neutrophils into macrophages by growth factors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only